Illumina Quarterly Cash Flow Statement
NASDAQ: ILMNHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Illumina free cash flow
In the quarter ended Jun 28, 2026, Illumina generated $201.0 million of operating cash flow and spent $40.0 million on capital expenditures. That left free cash flow of $161.0 million, a free-cash-flow margin of 13.9% of revenue. Free cash flow was down 21.1% from the prior year's $204.0 million.
Illumina returned $128.0 million to shareholders through share repurchases, equal to 80% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Illumina cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-28 | Q1 20262026-03-29 | Q4 20252025-12-28 | Q3 20252025-09-28 | Q2 20252025-06-29 | Q1 20252025-03-30 | Q4 20242024-12-29 | Q3 20242024-09-29 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-10-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 207.00M | 134.00M | 334.00M | 150.00M | 235.00M | 131.00M | 186.00M | 705.00M | -1.99B | -126.00M | -176.00M | -754.00M |
| Net Income growth (YoY) | -11.91% | +2.29% | +79.57% | -78.72% | — | — | — | — | — | -4300.00% | — | — |
| Depreciation & Amortization | 51.00M | 51.00M | 66.00M | 67.00M | 68.00M | 69.00M | 71.00M | 70.00M | 105.00M | 108.00M | 60.00M | 59.00M |
| Stock-Based Compensation | 73.00M | 60.00M | 63.00M | 70.00M | 69.00M | 73.00M | 79.00M | 83.00M | 112.00M | 96.00M | 94.00M | 87.00M |
| Change in Working Capital | -18.00M | 44.00M | -18.00M | -28.00M | -76.00M | -9.00M | -23.00M | -554.00M | 132.00M | -19.00M | 78.00M | -8.00M |
| Operating Cash Flow | 201.00M | 289.00M | 321.00M | 284.00M | 234.00M | 240.00M | 364.00M | 316.00M | 80.00M | 77.00M | 224.00M | 139.00M |
| Capital Expenditures | -40.00M | -38.00M | -55.00M | -31.00M | -30.00M | -32.00M | -29.00M | -32.00M | -31.00M | -36.00M | -51.00M | -45.00M |
| Investing Cash Flow | -122.00M | -366.00M | 108.00M | -51.00M | -49.00M | -63.00M | -48.00M | -41.00M | -41.00M | -48.00M | -85.00M | -53.00M |
| Share Repurchases | -128.00M | -242.00M | -42.00M | -130.00M | -370.00M | -200.00M | -17.00M | -99.00M | 0 | 0 | 0 | — |
| Debt Issued | — | — | 495.00M | — | — | — | 0 | — | — | — | — | — |
| Financing Cash Flow | -129.00M | -251.00M | -63.00M | -115.00M | -371.00M | -195.00M | -47.00M | -332.00M | -226.00M | 35.00M | -27.00M | -707.00M |
| Net Change in Cash | -49.00M | -329.00M | 368.00M | 116.00M | -179.00M | -14.00M | 258.00M | -51.00M | -188.00M | 60.00M | 121.00M | -626.00M |
| Free Cash Flow | 161.00M | 251.00M | 266.00M | 253.00M | 204.00M | 208.00M | 335.00M | 284.00M | 49.00M | 41.00M | 173.00M | 94.00M |
This table shows 12 quarterly periods of Illumina's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ILMN's reporting calendar. What is a cash flow statement?